Amoxicillin

阿莫西林

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameAmoxicillin
Drug Alias Name羟氨苄青霉素Amoxicillin PULSYSAmoxicillinum安莫西林安默西林 +[30] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCommunity Acquired PneumoniaHelicobacter pylori infectionLower Respiratory Tract Infections +[26] 
Global Approved IndicationsTonsillitisPharyngitisBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1974/01/18
Country/TerritoryCanadaUnited StatesUganda +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityUS Antibiotics LLCSohag University +[8] 
Inactive CompaniesAdvancis Pharmaceutical CorporationGlaxosmithkline PlcWake Forest University Health Sciences +[15] 
Active IndicationsCommunity Acquired PneumoniaHelicobacter pylori infectionParturition +[9] 
Inactive IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsInflammation +[17] 

Other Information

ATC CodeJ01CA04
Related LinksN/A